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ABSTRACT
Many mental health disorders such as schizophrenia, bipolar disorders, and recurrent major
depression have a common significant genetic risk factor called Disrupted-In-Schizophrenia-1 (or
DISC1) which codes for an 854-amino acid protein. Because of the lack of structural informa-
tion of the protein product of this gene, the molecular mechanisms underlying these conditions
remain elusive. DISC1 is an oligomeric protein that was found to be expressed in neurons and
glia and localized in many subcellular compartments such as synapses, nuclei, centrosomes, mi-
tochondria, and endoplasmic reticula. With over 158 interactors identified by yeast two-hybrid,
DISC1 appears to function as a sca↵olding hub to assemble multiple proteins into functional units.
Pos-translational modifications have also been known to play an essential role in regulating DISC1
activity and its oligomerization state. Particularly, the PKA-induced phosphorylation at S58 has
been shown to prevent the interaction with ATF4 and phosphorylation at S713 has been shown to
abolish the interaction with GSK3 . In this work, we showed that phosphorylation at S713 a↵ects
the oligomeric state of the protein by inducing a conformational change of the protein using size
exclusion chromatography and HDX-MS. We found that the phosphomimetic mutant S713 is not
a good replacement for the actual phosphorylated DISC598 because it showed little change in con-





Many mental health disorders such as schizophrenia, bipolar disorders, and recurrent major
depression have a common significant genetic risk factor called Disrupted-In-Schizophrenia-1 (or
DISC1) which codes for an 854-amino acid protein (Millar et al. (2001), Millar et al. (2000),
Tomppo et al. (2009), Hotta et al. (2011), Tomppo et al. (2012), Porteous et al. (2014)). Due to
the lack of structural information of the protein product of this gene, the molecular mechanisms
underlying these conditions remain elusive. The DISC1 protein is an oligomeric protein that was
found to be expressed in neurons and glia and localized in many subcellular compartments such as
synapses, nuclei, centrosomes, mitochondria, and endoplasmic reticula (Kirkpatrick et al. (2006),
Park et al. (2010)). It was also found to play an important role in early development, regulating
multiple cellular functions including cytoskeletal processes and intracellular transport (Devine et al.
(2016), Wang and Brandon (2011)), dendritic spine plasticity (Hayashi-Takagi et al. (2010)), neural
migration and neurite outgrowth (Ye et al. (2017a), Mao et al. (2009)). The expression level of
DISC1 is at its highest during the neonatal-infancy period but then gradually decreases with age
in the human brain (Schurov et al. (2004), Nataka et al. (2009)). The expression is also regulated
by alternative splicing mechanisms and over 50 splice variants that are translated into truncated
DISC1 proteins have been identified so far (Nataka et al. (2009)). Significantly, patients with
schizophrenia and other mental disorders have an increase in the expression of these alternatively
spliced transcripts of DISC1 (Nataka et al. (2009), Newburn et al. (2011)). Other than the original
translocation mutation (Millar et al. (2000), Millar et al. (2001)) and a C-term frame-shift deletion
(Sachs et al. (2005)) both leading to truncated protein products, several nonsynonymous variants
such as R264Q and L607F have been associated with major mental disorders (Zhang et al. (2006),
Moua↵ak et al. (2011)). With over 158 interactors identified by yeast two-hybrid (Camargo et al.
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(2007)), DISC1 appears to function as a sca↵olding hub to assemble multiple proteins into functional
units. Even though it is of critical importance, not much is known about the structural properties
of the DISC1 protein as well as the mechanism of forming complexes with other partner proteins.
DISC1 and other sca↵olding proteins have many common features. One particularly important
feature that they share is that they all contain fully or partially disordered regions which provide the
flexibility to interact with multiple binding partners with high specificity in order to control many
cellular signaling activities. Because of their larger size and disordered regions, these sca↵olding
proteins are di cult to study by structural biophysical techniques. In fact, most of our knowledge
on DISC1 protein has been provided so far by bioinformatics analysis. Multiple bioinformatic
tools predicted that DISC1 has a large disordered region (residue 1 to 325) at the N-terminal and
multiple ↵-helical and coiled coil motifs. There is a nuclear localization signal (NLS) motif at the
N-terminal close to the PKA phosphorylation site S58. It is also predicted that the central region
forms a discontinuous coiled-coil domain which is essential for its self-association. An early study by
Snachez-Pulido et al. had predicted the presence of two UVR domain within this region with two
↵-helices packed against each other in an anti-parallel hairpin fold (Sanchez-Pulido and Pointing
(2011)). There are also two predicted coiled-coil regions and two possible leucine zipper motifs
(Soares et al. (2011)). Partial structure of the C-terminal tail of DISC1 (765-835) in complex with
Nde1 had been solved, revealing a helix-turn-helix structure (Ye et al. (2017b)). This structure was
latter supported by the SAXS data by Korth’s group (Yerabham et al. (2018)). The C-terminal
region appears to have the characteristics of helical bundles that can be used to mediate interactions
with other partners. The full length protein has been shown to exist in equilibrium between
octamers and dimers; however, this equilibrium and the oligomerization state of the protein could
be a↵ected by single point mutations or truncations (Narayanan et al. (2011), Leliveld et al. (2008),
Leliveld et al. (2009)). Post-translational modifications have also been known to play an essential
role in regulating DISC1 activity and its oligomerization state. Particularly, the PKA-induced
phosphorylation at S58 has been shown to prevent the interaction with ATF4 and phosphorylation
at S713 has been shown to abolish the interaction with GSK3  (Ishizuka et al. (2011)). The binding
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site of GSK3  on DISC1 had been shown to be spanning the residues 1-220 and 356-595 (Mao et al.
(2009)). This means that the phosphorylation at S713 must have a long-range e↵ect on the binding
of these two proteins. We hypothesize that the phosphorylation induces an overall conformational
change which blocks the binding site of DISC1 with GSK3 .
In this thesis, we decided to work with only the C-terminal (amino acid 598-854) region of the
full length DISC1 protein. This is believed to be the missing fragment of DISC1 in schizophrenic
patients due to the breakpoint of a (1:11) chromosomal translocation. From here on, we will call
this C-terminal region DISC598. We found that DISC598, in agreement with the literature, formed
a large oligomer. We hypothesize that phosphorylation will change the conformation of the protein
leading to the breakdown of the oligomer into smaller species. Here, we attempt to provide evidence
for the conformational change of DISC598 upon phosphorylation at S713 leading to a change in the
oligomeric state of the protein, mainly by using Hydrogen-Deuterium Exchange Mass Spectrometry
(HDX-MS). We found that the phosphomimetic mutant S713 is not a good replacement for the
actual phosphorylated DISC598 because it showed little change in conformation. Furthermore,
we also provided in vitro evidence for the interaction of DISC598 with the bZiP region of the
transcription factor ATF4 that is known to regulate cell division and endoplasmic reticulum stress
response.
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CHAPTER 2. METHODS AND PROCEDURES
2.1 Construct Generation
cDNA encoding for human DISC598 (RefSeq accession number NP 061132.2) was codon opti-
mized for E. coli expression (Thermo Fisher Scientific) then cloned into pET28b(+) between NheI
and EcoRI sites. The sequence identity of DISC598 was confirmed by sequencing.
2.2 Expression Test
pET28b(+) vector containing the DISC598 gene was transformed into BL21 cells. The cells
were grown at 37  C in 200 mL of LB media until reaching OD of 0.4. 100 mL of the 200 mL
LB culture was aliquoted into four 25 mL cultures and cooled on ice. The remaining 100 mL LB
culture was incubated at 37  C until reaching OD of 1.0 then aliquoted into four 25 mL cultures
and cooled on ice. 0.4 mM final concentration of IPTG was added to each aliquot. The set of
low OD (0.4) aliquots was grown at the following temperature and time: 16  C overnight, 25  C
overnight, 37  C for 4 hours, and 37  C overnight. The same was done for the set of high OD
(1.0) aliquots. Cells were harvest at 4700 RPM and each time point was resuspended in 500 µL of
deionized water. Samples were analyzed on SDS-PAGE gel.
2.3 Solubility Test
pET28b(+) vector containing the DISC598 gene was transformed into BL21 cells. The cells
were grown at 37  C in 150 mL of LB media until reaching OD between 0.4-0.6 then cooled on
ice for 1h before overnight induction with 0.4 mM final concentration of IPTG at 16  C. The 150
mL culture was aliquoted into 10 mL cultures and harvested at 4700 RPM. The cell pellets were
resuspended in 500 µL the following solubilization solutions (all contain 50 mM bu↵er and 150 mM
NaCl unless stated di↵erently): sodium acetate pH 4.6, sodium citrate pH 5.0, sodium citrate pH
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5.5, MES pH 6.0, MES pH 6.5, HEPES pH 7.0, HEPES pH 7.5, Tris pH 8.0, Tris pH 8.5, CHES
pH 9.0, CHES pH 9.5, CHES pH 10.0, HEPES pH 7.0 + 2 M Urea, and HEPES 7.0 + 500 mM
NaCl. Samples were analyzed on SDS-PAGE gel.
2.4 Purification of DISC598
pET28b(+) vector containing the DISC598 gene was transformed into BL21 cells. The cells
were grown at 37  C in 1 L of LB media until reaching OD between 0.4-0.6 then cooled on ice
for 1h before overnight induction with 0.4 mM final concentration of IPTG at 16  C. Cells were
harvested at 5000 RPM and resuspended in 15 mL of lysis bu↵er (50 mM HEPES 7.0, 150 mM
NaCl, 2 M Urea, and 5 mM Imidazole). Cells were lysed by sonication and then centrifuged at
16,000 RPM for 1h. Lysate was loaded onto Ni-NTA column equilibrated with W1 bu↵er (50 mM
HEPES 7.0, 150 mM NaCl, 20 mM Imidazole). Ni-NTA column was washed with 300 mL of W1
bu↵er and 150 mL of W2 bu↵er (50 mM HEPES 7.0, 150 mM NaCl, 50 mM Imidazole). Protein was
eluted with elution bu↵er (50 mM HEPES 7.0, 150 mM NaCl, 350 mM Imidazole) then dialyzed
overnight against 4L of dialysis bu↵er (25 mM HEPES 7.0, 50 mM NaCl). Some precipitation was
observed during dialysis and was removed by centrifugation at 4,700 RPM. Protein was stable at
4  C for approximately 2 weeks. The phosphomimetic mutant S713D was purified following the
same procedure.
2.5 Circular Dichroism (CD)
Sample of DISC598 was prepared at concentration 0.5 mg/mL in 25 mM HEPES pH 7.0, 50
mM NaCl. Sample was added to an open top short-path demountable 20/O-Q-quartz cuvette. For
measurement, the MOS-500 (Biologic) instrument was used. Bio-kine 32 (version 4.73) was used




DISC598 was phosphorylated with PKA catalytic subunit following the recommended NEB
procedure. The reaction was performed at 4  C overnight with a final protein concentration of 15
µM. The S713 phosphorylation site was confirmed by mass spectrometry. Phosphorylated DISC598
was stable for 1-2 days at 4  C.
2.7 Size Exclusion Chromatography
Protein samples were loaded onto SuperdexTM75 Increase 10/300 GL (GE Healthcare Bio-
Sciences) and SuperdexTM200 10/300 GL (GE Healthcare Bio-Sciences) pre-equilibrated with
running bu↵er (25 mM HEPES 7.0, 50 mM NaCl).
2.8 Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS)
Deuterium exchange was initiated by diluting protein stocks (15 µM) into bu↵ered D2O (33
mM HEPES 7.0, 100 mM NaCl). Exchange was quenched at 10 s, 60 s, 180 s, and 3600 s by
addition of quench bu↵er (200 mM KPi 1.50, 4 M GuHCl) to pH 2.5 and final volumne of 100 µL
and flash frozen in liquid N2. Quenched exchange reactions were stored at -80  C until LC-MS
analysis was performed. All reactions were performed as three replicates.
Each time point sample was thawed and injected (100 µL) into a temperature-controlled AC-
QUITY UPLC M-class HDX platform coupled in-line to an ESI-Q-TOF Synapt G2-Si (Waters)
Mobile phases consisted of solvents A (HPLC-grade aqueous 0.1% formic acid) and B (HPLC-grade
acetonitrile, 0.1% formic acid). The samples were digested by passing through an in-line Enzymate
BEH-immobilized pepsin column (5 µm particle, 300 pore, 2.1 30 mm; Waters) at 25 C with a
flow rate of 50 µL/min. The peptides were accumulated on an Acquity UPLC BEH C18 VanGuard
trap column (1.7 µm, 130 , 2.1 5 mm; Waters) and desalted with 100% solvent A for 1.5 min
at a flow rate of 120 µL/min. The Peptides were then resolved on an Acquity UPLC BEH C18
analytical column (1.7 µm, 130 , 1 100 mm; Waters) using a 7 min linear gradient of 6% to 35%
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solvent B. Mass spectrometry data was collected in positive ion, MSE continuum, resolution mode
with an m/z range of 50 2000. Ion mobility was used to further resolve peptides in the gas phase.
Peptides were fragmented by argon gas collision for data-independent acquisition.
The peptides were identified by ProteinLynx Global Server (PLGS ver. 3.0.3, Waters). The
data were analyzed with DynamX ver. 3.0 software (Waters). Peptides that were identified by
PLGS were manually curated after establishing thresholds of identifications in 2 of 3 unlabeled
samples and 0.2 fragments per residue.
2.9 Transmission Electron Microscopy (TEM)
DISC598 and phosphorylated DISC598 samples were prepared by diluting to 100 nM with
dialysis bu↵er. Each sample (3 µL) was applied to a glow-discharged EM grid with coated with a
continuous carbon-film for 30 seconds. Excess protein was removed by blotting with filter paper
and each grid was washed o↵ with water twice before applying negative stain solution (0.75%
uranium formate). EM images were collected using a 200kV JEOL 2100 scanning/transmission
electron microscope. A total of 82 images were collected at 200 kV and 60,000x magnification.
Particle picking and 2D classification was performed in Scipion run on the Iowa State RIT1 server
(https://researchit.las.iastate.edu/rit1). Particles were initially picked manually to create templates
for automated picking. Initial particles were aligned and classified using Maximum Likelihood. Junk
classes were removed and the remaining 7000 particles were aligned into 64 classes using CL2D.
2.10 Pulldown Assay with bZiPATF4
GST column was used to perform pulldown assay. In a 1.5 mL tube, 200 µL of slurry GST
beads were added. The tube was centrifuged at 5000 RPM for 1 min, then the supernatant was
removed. 1 mL of washing bu↵er (50 mM HEPES pH 7.5, 200 mM NaCl) was added to the tube
and the tube was centrifuged again at 5000 RPM for 1 min. Supernatant was removed and the this
washing step was repeated for 4-5 times.
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For the control, 0.2 mg of bZiPATF4 only was added to one GST column and incubated for 30
mins. In a di↵erent column, 0.2 mg of DISC598 was added and incubated for 30 mins. For the
sample, 0.2 mg of bZiPATF4 was added to another GST column and incubated for 30 mins. Then
both the controls and the sample were washed with 1 mL of washing bu↵er each. This washing
step was repeated for 5 times. 0.2 mg of DISC598 was then added to the sample. This sample was
heated at 65  C for 2 mins. Another sample was prepared in the same manner without heating.
The washing step was repeated for another 5 times. The samples were analyzed on SDS-PAGE gel.
2.11 DISC598 Crystallization
Crystals of the 6XHis DISC598 were obtained using sitting-drop vapor di↵usion. A 2 µL protein
solution containing 10 mg/mL DISC598 in 25 mM HEPES pH 7.0, 50 mM NaCl was mixed with
a 2 µL of reservoir soution contaning 0.2 M NaF, 0.1 M Tris-HCl pH 7.5, and 28% PEG 400. The
resultant mixture was equilibrated against 500 µL of the reservoir solution at room temperature.
Crystals of DISC598 grew to a full size in the drops within one week. Crystals were flash-cooled,
using solution containing 25% glycerol as cryoprotectant before data collection. Data collection
was done at the Macromolecular X-Ray Facility at Iowa State University using Rigaku MicroMax




6XHis-DISC598 was highly expressed at lower OD (0.4). The best condition for expression
was 25  C overnight (Figure 3.1). Both 37  C 4 hours and overnight gave adequate expression;
however, there was more contamination at these conditions. At higher OD (1.0), the expression is
much lower with 25  C overnight being the best condition. We finally decided to chose the 16  C
overnight condition for solubility test because it had the least amount of contamination.
3.2 Solubility Test
We tested the solubility of DISC598 in multiple di↵erent solubilizing solutions with a pH range
from 4.6 to 10.0. The solubility increases with increasing pH with pH 10.0 being the best condition.
However, the HEPES pH 7.0 + 2 M urea condition gave the largest amount of soluble protein
(Figure 3.2).
3.3 Protein Purification
6XHis-DISC598 bound tightly to Ni-NTA beads, yielding large quantity of protein from 1L
culture with >95% purity (Figure 3.3). However, some amount of protein precipitated during
dialysis and the precipitated protein could be removed by centrifugation at 4700 RPM. Protein
remained stable at 4  C for approximately 2 weeks.
3.4 Circular Dichroism
Because we used 2 M urea in lysis bu↵er, we wanted to check whether the protein is still fully
folded after we remove urea during washing steps using circular dichroism. The CD spectrum of
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Figure 3.1 SDS-PAGE gel of DISC598 expression test. From left to right: standards
(Precision Plus ProteinTM Dual Color), 16  C overnight (OD 1.0), 25  C
overnight (OD 1.0), 37  C 4h (OD 1.0), 37  C overnight (OD 1.0), 16  C
overnight (OD 0.4), 25  C overnight (OD 0.4), 37  C 4h (OD 0.4), 37  C
overnight (OD 0.4), Precision Plus ProteinTM Dual Color).
DISC598 indicated a fully folded protein with predicted secondary structure percentages 82.2%
alpha helix and 1.15% beta strand (Figure 3.4).
3.5 Size Exclusion Chromatography
The SuperdexTM75 size exclusion profile of DISC598 showed a single oligomeric peak near
the void volume (Figure 3.5). However, after phosphorylation, the profile indicated the presence of
lower molecular weight species. This change was confirmed by passing DISC598 and phosphorylated
DISC598 through the SuperdexTM200 size exclusion (Figure 3.6). The SuperdexTM200 profiles
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Figure 3.2 SDS-PAGE gel of DISC598 solubility test. From left to right: standards (Pre-
cision Plus ProteinTM Dual Color), sodium acetate pH 4.6, sodium citrate pH
5.0, sodium citrate pH 5.5, MES pH 6.0, MES pH 6.5, HEPES pH 7.0, HEPES
pH 7.5, Tris pH 8.0, Tris pH 8.5, CHES pH 9.0, CHES pH 9.5, CHES pH 10.0,
HEPES pH 7.0 + 2 M Urea, and HEPES 7.0 + 500 mM NaCl.
were consistent with those of SuperdexTM75. These results suggested that there was a significant
structural change upon phosphoyrlation. Therefore, we decided to confirm this by performing
HDX-MS and TEM experiments. The phosphomimetic mutant S713D resulted in a similar profile
to that of wtDISC598 (data not shown), with a single oligomeric peak near the void volume.
This indicates that there was no significant di↵erence between the S713D mutant and DISC598.
However, we decided to confirm this by performing HDX-MS experiment on this mutant.
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Figure 3.3 SDS-PAGE gel of DISC598. From left to right: standards (Precision Plus
Protein
TM Dual Color), lysate, purified DISC598.
3.6 HDX-MS
Size exclusion profiles of wtDISC598 and phosphorylated DISC598 indicated that there was
a significant conformational change upon phosphorylation. This conformational change might be
important for the interactions of DISC598 with its partners. Therefore, we performed HDX-MS
analysis to examine the regions a↵ected by this phosphorylation. Pepsinization resulted in 369
uniquely identifiable peptides for DISC598, 762 peptides for phosphorylated DISC598 (Figure 3.8),
and 148 peptides for the phosphomimetic mutant S713D (Figure 3.7). The significant di↵erence
in pepsinization between DISC598 and phosphorylated DISC598 suggested that there might be
a structural di↵erence between the two. Relative uptake vs. residue number plot (Figure A.7)
and the butterfly plot of DISC598 and the mutant S713D indicated that there was a small change
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Figure 3.4 CD Spectrum of DISC598. K2D3 predicted secondary structure percentages of
82.2% alpha helix and 1.15% beta strand.
in conformation near the 760 residue (Figure 3.9). However, the butterfly plot of DISC598 vs.
phosphorylated DISC598 (Figure 3.10) showed a significant overall change in conformation upon
phosphorylation.
The peptides phosphorylated at S713 showed less exposure compared to the unphosphorylated
DISC598. However, the N-terminal region of the phosphorylated DISC598 showed more exposure
compared to DISC598. These changes in conformation might account for the di↵erent SEC pro-
files of DISC598 and phosphorylated DISC598. Thus, to further show that this change is indeed
significant, we decided to use TEM to image the di↵erences between the two samples.
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3.7 TEM
The TEM images of DISC598 showed larger particles, consistent with the SEC profiles. Smaller
particles were observed for phosphorylated DISC598. See appendix (Figure A.8) for classification
of particles.
3.8 Pulldown Assay with bZiPATF4
Heating both DISC598 and bZiPATF4 together at 65  C showed weak interaction between the
2 proteins. The sample without heating did not show any significant interaction (Figure 4.16).
3.9 DISC598 Crystallization
Crystals of DISC598 grew to full size within one week of crystallization. Most drops have only
one or two crystals (Figure 4.17). These crystals were flash-cooled and mounted on the Rigaku
MicroMax 007HF X-ray generator coupled to a R-Axis IV++ detector and di↵raction images were
collected. However, these crystals all showed a disordered di↵raction pattern which is not fit for
data collection and structural determination.
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Figure 3.5 SuperdexTM75 profile of DISC598 and phosphorylated DISC598. Chro-
matogram shows a peak shift to the lower molecular weight region, indicating
there was a conformational change upon phosphorylation.
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Figure 3.6 SuperdexTM200 profile of DISC598 and phosphorylated DISC598. Chro-
matogram shows a peak shift to the lower molecular weight region, indicating
there was a conformational change upon phosphorylation.
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Figure 3.7 Coverage map of the phosphomimetic mutant S713D. Pepsinization resulted
in 148 uniquely identifiable peptides for the S713D mutant. The C-terminal
shows less exposure compared to the N-terminal. The peptides contain residue
760 shows more exposure which indicates that there is a small conformational
change near this region of the mutant.
Figure 3.8 Coverage map of the phosphorylated DISC598. Pepsinization resulted in 762
uniquely identifiable peptides for the phosphorylated DISC598. Peptides near
the N-terminal showed more exposure for the phosphorylated DISC598. The
C-terminal of the phosphorylated DISC598 showed less exposure than the un-
phosphorylated DISC598.
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Figure 3.9 Butterfly plot of DISC598 and the phosphomimetic mutant S713D. Blue =
0.167 min, Green = 3 min, Yellow = 10 min, and Red = 60 min. Small change
observed between residue 760 and 780.
Figure 3.10 Butterfly Plot of DISC598 vs. Phosphorylated DISC598. Orange = 1 min,
Black = 60 min. Significant overall change observed for DISC598 upon phos-
phorylation. The peptides phosphorylated at S713 showed less exposure com-
pared to the unphosphorylated DISC598. However, the N-terminal region of
the phosphorylated DISC598 showed more exposure compared to DISC598.
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Figure 3.11 TEM image of DISC598. A) Larger particles were observed before phospho-
rylation. B) Smaller particles were observed after phosphorylation.
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Figure 3.12 SDS-PAGE gel of DISC598/bZiPATF4 pulldown assay. From left to right:
bZiPATF4 only, DISC598 only, standards (Precision Plus ProteinTM Dual
Color), washing steps (1-3), bZiPATF4 control , DISC598 control, sample 1
(no heating at 65  C), sample 2 (with heating at 65  C).
Figure 3.13 Crystals of DISC598. These crystals were obtained using vapor di↵usion
method. Crystal condition: 0.2 M NaF, 0.1 M Tris-HCl pH 7.5, and 28%
PEG 400. Crystals of DISC598 grew to a full size in the drops within one
week.
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Figure 3.14 Di↵raction image of DISC598 crystal. All crystals from this condition showed
a similar disordered di↵raction pattern.
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CHAPTER 4. SUMMARY AND DISCUSSION
DISC598 was successfully purified with >95% purity and the protein remained stable for more
than two weeks. Upon phosphorylation with PKA catalytic subunit, DISC598 became unstable
and precipitated within one day after phosphorylation. This indicates that phosphorylation led
to a conformational change making the protein less stable. SEC profiles of DISC598 consistently
showed a single oligomeric peak. This could explain the reason DISC598 remained stable for an
extended amount of time. After phosphorylation, SEC profiles showed lower molecular weight
peaks associated with roughly dimeric and trimeric species. To show that these di↵erences between
DISC598 and phosphorylated DISC598 were due to the conformational change upon phosphoyrla-
tion, we utilized HDX-MS technique to probe the regions of the protein that are a↵ected by this
phosphorylation.
Pepsinization results showed that the DISC598 and phosphorylated DISC598 were digested
di↵erently resulted in the phosphorylated DISC598 having more uniquely identifiable peptides
than DISC598. This is consistent with our hypothesis that the phosphorylated DISC598 is less
stable and with the SEC profiles. The butterfly plot of DISC598 vs. phosphorylated DISC598
indicated that there was indeed an overall conformational change upon phosphorylation with the
N-terminal of phosphorylated DISC598 being more exposed to deuterium exchange and the region
near the phosphorylation site S713 being less exposed than non-phosphorylated DISC598. This
change in conformation upon phosphorylation could explain the di↵erence in stability of the protein
between DISC598 and phosphorylated DISC598. DISC1 is a sca↵olding protein and might requires
constant interactions with its partners to stabilize itself. This could explain the reason purified
DISC598 forms oligomers to stabilize the interaction sites. Phosphorylation might force the protein
to breakdown into smaller species thus destabilize the protein. However, this might be important
for its interaction with other partner proteins. We further confirmed the dissociation from large
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oligomers to smaller species between DISC598 and phosphorylated DISC598 with TEM imaging.
The particles observed for DISC598 were much larger in size compared to those of phosphorylated
DISC598. We also perform the particle classification (see appendix) in an attempt to perform
3D-reconstruction. However, due to the lack of resolution, we did not obtain a good 3D image for
the protein.
Phosphomimetic mutants are generally very useful because they can replace the phosphorylation
procedure which takes time to optimize. Here, we constructed a phosphomimetic S713D mutant of
DISC598 to see if this could be used for future experiments such as crystallization and interaction
studies. However, the butterfly plot of DISC598 vs. the S713D mutant showed little di↵erence
in terms of structural changes. The most significant change between the two constructs being the
region near residue 760. Furthermore, the SEC profiles of DISC598 and the mutant S713D showed
similar results with a single oligomeric peak. The HDX-MS data of phosphorylated DISC598
showed significant changes to the overall conformation of the protein due to phosphorylation. This
indicates that this phosphomimetic mutant is not an ideal construct for future studies.
In addition, the PKA-induced phosphorylation at S58 has been shown to prevent the interaction
with ATF4 and phosphorylation at S713 has been shown to abolish the interaction with GSK3 
(Ishizuka et al. (2011)). The binding site of GSK3  on DISC1 had been shown to be spanning
the residues 1-220 and 356-595 (Mao et al. (2009)). This means that the phosphorylation at S713
must have a long-range e↵ect on the binding of these two proteins. We hypothesized that the
phosphorylation induces an overall conformational change which blocks the binding site of DISC1
with GSK3 . Our data showed that phosphorylation at S713 a↵ected the overall conformation of
the DISC598 construct which could lead to an overall structural change of the DISC1 protein.
We also confirmed the interaction of DISC598 with ATF4 by performing the pulldown assay
using the bZiP region of ATF4. The two proteins showed weak interaction upon heating to 65
 C for 2 mins. However, the sample without heating to 65  C did not show any interaction. We
suspected that the protein did not interact without heating because DISC598 formed large, stable
oligomer as indicated by native gel and size exclusion chromatography. The heating might have shift
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the equilibrium more towards the lower molecular weight species, allowing the protein to interact
with bZiPATF4. For future studies, we will perform the same pulldown assay with phosphorylated
DISC598 to see if phosphorylation plays a role in controlling the interaction of DISC598 with the
transcription factor ATF4.
Lastly, we performed crystallization of DISC598 using hanging drop vapor di↵usion technique.
We successfully obtained crystals large enough for the Rigaku MicroMax 007HF X-ray generator
coupled to a R-Axis IV++ detector without the need for going to the Advanced Photon Source.
However, the crystals all gave a disordered di↵raction pattern which was not suitable for further
data collection and structural determination. We suspected that the 6XHis tag might have caused
the disorderness of the di↵raction pattern and proceeded to remove the tag with thrombin cleav-
age. However, removing the 6XHis tag did not improve the di↵raction pattern. We then tried to
crystallize the protein using seeding technique and lowering the temperature to 4  C. However, this
also did not improve the di↵raction pattern of DISC598. We also tried to change the 6XHis tag to
the C-terminal of DISC598. However, we had not been successful in purifying this construct. The
expression of the C-terminal 6XHis tag DISC598 was much lower than that of the N-terminal 6XHis
tag construct. For future experiments, we could try to crystallize the phosphorylated DISC598 to
see if this would improve the di↵raction pattern.
Even though we were not successful in obtaining a good di↵raction image of the DISC598 pro-
tein, our CD data did provide some insights into the secondary structures of the protein. The CD
spectrum of DISC598 indicated a fully folded protein with predicted secondary structure percent-
ages 82.2% alpha helix and 1.15% beta strand. In addition, with further analysis, our HDX-MS
data could be used to provide more basic information about the secondary structures of the protein.
In conclusion, we showed that phosphorylation at S713 a↵ects the oligomeric state of the protein
by inducing a conformational change of the protein using size exclusion chromatography and HDX-
MS. We found that the phosphomimetic mutant S713 is not a good replacement for the actual
phosphorylated DISC598 because it showed little change in conformation. We also provided in
vitro evidence for the interaction of DISC1 with the transcription factor ATF4.
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Figure A.1 SDS-PAGE gel of DISC598 Purification Process. From left to right: standards
(Precision Plus ProteinTM Dual Color), pellet, lysate, flow-through, Ni-NTA
column fractions.
Figure A.2 SDS-PAGE gel of the phosphomimetic mutant. From left to right: standards
(Precision Plus ProteinTM Dual Color), pellet, Ni-NTA column fractions.
APPENDIX. SUPPLEMENTAL MATERIA  
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Figure A.3 Native gel of DISC598. From left to right: standards (Precision Plus
Protein
TM Dual Color), DISC598. The majority of the DISC598 protein
formed high molecular-weight oligomer. However, bands corresponding to
trimer (92 KDa) and tetratmer (124 KDa) were also observed
A.1 Purification of bZiPATF4
bZiPATF4 was provided by Steven Siang (graduate student in Roche Lab). Briefly, the protein
was expressed in BL21 (pGEX-4T1 vector) at 16  C overnight. After cell harvest, the cells were
lysed in lysis bu↵er of 50 mM HEPES pH 7.5, 200 mM NaCl. Lysate was loaded onto GST-column
and washed with 300 mL of lysis bu↵er. Protein was eluted with lysis bu↵er contaning 10 mM
reduced glutathione.
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Figure A.4 HDX-MS Uptake Chart of the phosphomimetic Mutant S713D
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Figure A.5 HDX-MS Uptake Chart of the phosphorylated DISC598
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Figure A.6 Mass spectrometry Confirmation of Phosphorylation at S713 with PKA cat-
alytic subunit
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Figure A.7 Relative uptake vs. residue number plot of DISC598 and the phosphomimetic
mutant S713D. Significant change observed between residue 760 and 780.
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Figure A.8 Classification of Particles. Particle picking and 2D classification was performed
in Scipion run on the Iowa State RIT1 server. Particles were initially picked
manually to create templates for automated picking. Initial particles were
aligned and classified using Maximum Likelihood. Junk classes were removed
and the remaining 7000 particles were aligned into 64 classes using CL2D
